BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3307756)

  • 1. Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension.
    Reinfrank J; Eckardt A; Hahn KJ
    Bibl Cardiol; 1987; (42):156-60. PubMed ID: 3307756
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies with sustained-release verapamil in essential hypertension.
    Silke B
    Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
    Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
    Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive efficacy of sustained-release verapamil.
    Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
    J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypertension with a delayed-action form of verapamil and its effect on hypertrophy and function of the left ventricle].
    Spacek R; Kozák P; Stárek A; Hes I; Skalníková V
    Vnitr Lek; 1987 Nov; 33(11):953-61. PubMed ID: 2964119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
    Cedro K; Dłuzniewski M; Szpytma M
    Wiad Lek; 1993 Dec; 46(23-24):885-92. PubMed ID: 7900383
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma levels and noninvasive hemodynamic profile of slow release verapamil (240 mg). A multicenter study].
    Vulpis V; Seccia TM; Ricci S; Pirrelli A
    Riv Eur Sci Med Farmacol; 1993; 15(5-6):227-35. PubMed ID: 7761676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of isoptin SR-240 in treatment of hypertension].
    Knypl K; Brym E; Wacławek-Maczkowska J
    Wiad Lek; 1993 Dec; 46(23-24):898-901. PubMed ID: 7900385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose initiation of calcium antagonists in the treatment of hypertension.
    Müller FB; Erne P; Hotz M; Bolli P; Follath F; Bühler FR
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):118S-124S. PubMed ID: 3794763
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of verapamil in hypertensive crisis].
    Gushi N; Mateos DA; Magaldi JB
    Arq Bras Cardiol; 1976 Feb; 29(1):67-74. PubMed ID: 779727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Verapamil in the hypertensive crisis].
    Chamma Neto M; Pinto MJ; Rojas RI; Santos LM; Glitz T; Blume Ldo R; Quintino E; Michelotto PV; Maranhão MF; Sobrinho MI
    Arq Bras Cardiol; 1985 Feb; 44(2):135-7. PubMed ID: 3910001
    [No Abstract]   [Full Text] [Related]  

  • 17. Once-daily verapamil--an objective evaluation in stable angina pectoris using treadmill exercise testing.
    Raftery EB
    Br J Clin Pract Suppl; 1985 Jun; 42():17-23. PubMed ID: 3929824
    [No Abstract]   [Full Text] [Related]  

  • 18. Verapamil for hypertension.
    Med Lett Drugs Ther; 1987 Apr; 29(737):37-8. PubMed ID: 3561323
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum concentration and antihypertensive effect of slow-release verapamil.
    Schütz E; Ha HR; Bühler FR; Follath F
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S346-9. PubMed ID: 6184566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily verapamil in hypertension: intra-arterial recording of blood pressure.
    Brigden GS; Caruana MP; Heber ME; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():48-52. PubMed ID: 3151271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.